S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:CYCC

Cyclacel Pharmaceuticals News Headlines

$6.17
+0.07 (+1.15 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.54
Now: $6.17
$6.29
50-Day Range
$6.10
MA: $7.88
$10.16
52-Week Range
$3.12
Now: $6.17
$19.25
Volume315,758 shs
Average Volume861,401 shs
Market Capitalization$30.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1.34

Headlines

Cyclacel Pharmaceuticals (NASDAQ CYCC) News Headlines Today

Source:
SourceHeadline
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Downgraded by Zacks Investment Research to SellCyclacel Pharmaceuticals (NASDAQ:CYCC) Downgraded by Zacks Investment Research to Sell
marketbeat.com - February 26 at 7:47 PM
Short Interest in Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Rises By 26.4%Short Interest in Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Rises By 26.4%
americanbankingnews.com - March 7 at 9:56 AM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 8.3%Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 8.3%
americanbankingnews.com - March 3 at 8:46 PM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Up 8.3%Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Up 8.3%
americanbankingnews.com - March 1 at 7:38 PM
-$0.49 EPS Expected for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) This Quarter-$0.49 EPS Expected for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) This Quarter
americanbankingnews.com - March 1 at 9:38 AM
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Expected to Post Earnings of -$0.49 Per ShareCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Expected to Post Earnings of -$0.49 Per Share
americanbankingnews.com - March 1 at 9:05 AM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Announces  Earnings Results, Misses Estimates By $0.83 EPSCyclacel Pharmaceuticals (NASDAQ:CYCC) Announces Earnings Results, Misses Estimates By $0.83 EPS
americanbankingnews.com - February 26 at 8:43 PM
Cyclacel Pharmaceuticals (CYCC) Scheduled to Post Quarterly Earnings on ThursdayCyclacel Pharmaceuticals (CYCC) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - February 20 at 9:14 AM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 8.7%Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 8.7%
americanbankingnews.com - February 18 at 8:54 PM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock Price Crosses Above Two Hundred Day Moving Average of $5.10Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock Price Crosses Above Two Hundred Day Moving Average of $5.10
americanbankingnews.com - February 18 at 2:52 AM
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 7%Cyclacel Pharmaceuticals (NASDAQ:CYCC) Trading Down 7%
americanbankingnews.com - February 10 at 8:38 PM
Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital ConferenceCyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference
finance.yahoo.com - February 10 at 8:24 AM
Ripster Makes The Case For Cyclacel On Benzingas Power HourRipster Makes The Case For Cyclacel On Benzinga's 'Power Hour'
msn.com - February 5 at 6:45 PM
35 Stocks Moving In Fridays Mid-Day Session35 Stocks Moving In Friday's Mid-Day Session
msn.com - January 15 at 2:48 PM
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
finance.yahoo.com - December 30 at 7:40 AM
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn BioventuresCyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
finance.yahoo.com - December 22 at 10:51 AM
Cyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of DirectorsCyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of Directors
finance.yahoo.com - December 21 at 7:46 AM
Cyclacel Pharmaceuticals EPS misses by $1.74Cyclacel Pharmaceuticals EPS misses by $1.74
seekingalpha.com - November 11 at 5:50 PM
Cyclacel Pharmaceuticals, Inc. to Host Earnings CallCyclacel Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 11 at 5:50 PM
Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial ResultsCyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 11 at 5:50 PM
Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020
finance.yahoo.com - October 26 at 9:00 AM
Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session at the 32nd EORTC-NCI-AACR Symposium 2020Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session at the 32nd EORTC-NCI-AACR Symposium 2020
finance.yahoo.com - September 21 at 7:42 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2020 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 11:43 PM
Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial ResultsCyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 12 at 6:42 PM
Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial ResultsCyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results
finance.yahoo.com - August 5 at 10:46 AM
Cyclacel (CYCC) to Report Q2 Earnings: Whats in the Offing?Cyclacel (CYCC) to Report Q2 Earnings: What's in the Offing?
www.nasdaq.com - July 28 at 3:02 PM
Cyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in CancerCyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer
finance.yahoo.com - July 13 at 7:23 AM
Edited Transcript of CYCC earnings conference call or presentation 12-May-20 8:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 12-May-20 8:30pm GMT
finance.yahoo.com - June 9 at 11:57 PM
3 Biotech Stocks Under $5 With Massive Upside Potential3 Biotech Stocks Under $5 With Massive Upside Potential
finance.yahoo.com - May 21 at 9:48 AM
Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial ResultsCyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results
finance.yahoo.com - May 5 at 7:39 AM
Mid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares PlungeMid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares Plunge
www.benzinga.com - April 21 at 1:58 PM
Company News for Apr 21, 2020Company News for Apr 21, 2020
finance.yahoo.com - April 21 at 1:58 PM
Cyclacel plummets 52% premarket on equity offeringCyclacel plummets 52% premarket on equity offering
seekingalpha.com - April 21 at 8:58 AM
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERINGCYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
finance.yahoo.com - April 21 at 8:58 AM
IVR, NVAX, SRG and EXEL among midday moversIVR, NVAX, SRG and EXEL among midday movers
seekingalpha.com - April 20 at 12:56 PM
Mid-Day Market Update: Crude Oil Plunges 45%; Cyclacel Pharmaceuticals Shares JumpMid-Day Market Update: Crude Oil Plunges 45%; Cyclacel Pharmaceuticals Shares Jump
www.benzinga.com - April 20 at 12:56 PM
Nano-Cap Cyclacel Rockets Higher On Launch Of Study For Coronavirus InflammationNano-Cap Cyclacel Rockets Higher On Launch Of Study For Coronavirus Inflammation
www.benzinga.com - April 20 at 12:56 PM
Cyclacel up 38% premarket on COVID-19 plan in UKCyclacel up 38% premarket on COVID-19 plan in UK
seekingalpha.com - April 20 at 7:56 AM
Cyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK Inhibitors to Reduce Runaway Inflammation in COVID-19 DiseaseCyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK Inhibitors to Reduce Runaway Inflammation in COVID-19 Disease
finance.yahoo.com - April 20 at 7:56 AM
When Will Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Breakeven?When Will Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Breakeven?
finance.yahoo.com - March 17 at 10:56 AM
Cyclacel files for offering via RothCyclacel files for offering via Roth
seekingalpha.com - March 13 at 11:50 PM
Edited Transcript of CYCC earnings conference call or presentation 26-Feb-20 9:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 26-Feb-20 9:30pm GMT
finance.yahoo.com - March 9 at 6:54 AM
50 Healthcare Stocks Moving In Fridays Pre-Market Session50 Healthcare Stocks Moving In Friday's Pre-Market Session
www.msn.com - February 28 at 2:13 PM
Cyclacel Pharmaceuticals IncCyclacel Pharmaceuticals Inc
www.bloomberg.com - February 27 at 6:04 PM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2019 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 12:08 AM
Cyclacel (CYCC) to Report Q4 Earnings: What's in the Cards?Cyclacel (CYCC) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 20 at 1:57 PM
Cyclacel Pharmaceuticals (CYCC) Presents At BIO CEO & Investor Conference 2020 - SlideshowCyclacel Pharmaceuticals (CYCC) Presents At BIO CEO & Investor Conference 2020 - Slideshow
seekingalpha.com - February 11 at 5:00 PM
Cyclacel Pharmaceuticals (CYCC) Presents At Biotech Showcase 2020 - SlideshowCyclacel Pharmaceuticals (CYCC) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 8:37 PM
Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2020 in San FranciscoCyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2020 in San Francisco
www.marketwatch.com - January 6 at 12:44 PM
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San FranciscoCyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco
finance.yahoo.com - January 6 at 12:44 PM
Introducing Cyclacel Pharmaceuticals (NASDAQ:CYCC), The Stock That Tanked 92%Introducing Cyclacel Pharmaceuticals (NASDAQ:CYCC), The Stock That Tanked 92%
finance.yahoo.com - December 11 at 9:20 AM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.